文献速递肥胖与代谢综合征

脂肪组织微生物DNA在肥胖相关代谢功能障碍中的作用

Deciphering the role of adipose tissue microbial DNA in obesity-related metabolic dysfunction.
PubMed 文献 · J Clin Endocrinol Metab · 2026-06-24

临床肥胖者肠道屏障受损、硫化氢产生菌富集,脂肪组织微生物DNA更多且多样性降低,其脂肪来源DNA在体外诱导脂肪细胞氧化应激、IL-1β与NFκB表达升高及脂联素/瘦素基因表达比值降低,提示肠-脂肪组织微生物轴可能参与肥胖代谢并发症。

要点

  • 临床肥胖者肠道屏障受损且硫化氢产生菌(Bilophila、Desulfovibrio)富集。
  • 临床肥胖者脂肪组织微生物DNA更多、多样性降低,且与肠道菌群部分重叠。
  • 临床肥胖者脂肪来源微生物DNA可在体外诱导脂肪细胞功能障碍。

核心结论

  • 临床肥胖以特定肠道菌群特征、肠道屏障受损及脂肪组织微生物DNA增多为特点。
  • 脂肪组织来源微生物DNA在体外促进脂肪细胞功能障碍,支持肠-脂肪组织微生物轴在肥胖相关代谢并发症中的潜在作用。

研究设计与样本

  • 探索性横断面研究,辅以体外机制实验。

主要发现

  • 临床肥胖与较高蛋白质摄入、肠道屏障功能受损及硫化氢产生菌属(Bilophila、Desulfovibrio)富集相关,而临床前肥胖中Akkermansia与Bifidobacterium较高。
  • 临床肥胖者脂肪组织含更多微生物DNA,多样性降低,且与肠道菌群部分重叠。
  • 与临床前肥胖来源DNA相比,临床肥胖脂肪来源微生物DNA在体外使脂肪细胞氧化应激增加、IL-1β与NFκB表达升高、脂联素/瘦素基因表达比值降低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Obesity-related metabolic complications are especially driven by adipose tissue dysfunction. Gut dysbiosis and impaired intestinal barrier function facilitate microbial fragment translocation, potentially promoting metabolic impairment. However, presence and functional impact of microbial DNA in adipose tissue and contribution to metabolic dysfunction remain unclear. OBJECTIVE: To investigate the role of gut microbiota, intestinal barrier function, and adipose tissue-associated microbial DNA in obesity-related metabolic dysfunction. DESIGN: Exploratory cross-sectional study with complementary mechanistic in vitro experiments. SETTING: Academic tertiary referral center in Lisbon, Portugal. PARTICIPANTS: Fifty adults with severe obesity undergoing laparoscopic Roux-en-Y gastric bypass surgery were recruited and stratified according to metabolic phenotype into pre-clinical obesity and clinical obesity. MAIN OUTCOME MEASURES: Gut microbiota composition, intestinal barrier markers, adipose tissue-associated microbial DNA profiles, and adipocyte functional responses to adipose tissue-derived microbial DNA. RESULTS: Clinical obesity was associated with higher protein intake, impaired gut barrier function, and enrichment of hydrogen sulfide-producing genera (Bilophila, Desulfovibrio), whereas pre-clinical obesity showed higher Akkermansia and Bifidobacterium. Adipose tissue from clinical obesity contained more microbial DNA, with reduced diversity and partial overlap with gut profiles. Functionally, adipose-derived microbial DNA from clinical obesity induced increased oxidative stress, IL-1β and NFκB expression, and a lower adiponectin/leptin gene expression ratio in adipocytes compared with pre-clinical obesity DNA. CONCLUSION: Clinical obesity is characterized by distinct gut microbiota signatures, impaired intestinal barrier function, and increased adipose-associated microbial DNA. Adipose tissue-derived DNA promoted adipocyte dysfunction in vitro, supporting a potential role for the gut-adipose tissue microbial axis in obesity-related metabolic complications.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ismael S, Vaz C, Durão C, et al. Deciphering the role of adipose tissue microbial DNA in obesity-related metabolic dysfunction. J Clin Endocrinol Metab. 2026. PMID: 42339619. doi:10.1210/clinem/dgag246

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。